STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Houlihan Lokey (HLI) Form 144 Reveals Proposed 6,811-Share Sale

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Houlihan Lokey (HLI) Form 144 summary: An insider filed a notice to sell 6,811 common shares on or about 09/16/2025 through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value reported at $1,380,898.92. The shares were acquired on 05/15/2025 as restricted stock that vested under a registered plan tied to services rendered.

The filing also reports a prior sale by the IRWIN N GOLD FAMILY TRUST of 5,000 shares on 06/30/2025 for gross proceeds of $914,028.50. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • Insider sale notice: Proposed sale of 6,811 shares with aggregate market value of $1,380,898.92, which may be viewed negatively by some investors
  • Recent prior sale: IRWIN N GOLD FAMILY TRUST sold 5,000 shares on 06/30/2025 for $914,028.50

Insights

TL;DR: Insider plans to sell vested restricted shares worth about $1.38M; prior sale of 5,000 shares realized $914K.

The Form 144 notifies the market of a proposed sale of 6,811 common shares scheduled for approximately 09/16/2025 through Morgan Stanley Smith Barney, with an indicated aggregate market value of $1,380,898.92. The shares originated from a restricted stock vesting event on 05/15/2025, tied to services rendered, which is a common executive compensation mechanism. The filing also discloses a recent sale by the IRWIN N GOLD FAMILY TRUST of 5,000 shares on 06/30/2025 for $914,028.50. For investors, these are routine insider-sale disclosures required for compliance and do not, by themselves, provide information about company performance.

TL;DR: Disclosure aligns with Rule 144 requirements; transaction appears to be vesting-driven, not an open-market planned disposition detail.

The notice shows restricted stock vesting as the acquisition event and lists the intended broker and exchange for sale. The filer attests no undisclosed material adverse information. The filing does not state a trading plan or 10b5-1 adoption date, so the sale appears to be a standard post-vesting disposition subject to Rule 144 timing and volume constraints. From a governance standpoint, this is a standard compliance disclosure rather than an indicator of corporate governance issues.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the HLI Form 144 disclose about the planned sale?

The Form 144 discloses a proposed sale of 6,811 common shares via Morgan Stanley Smith Barney on the NYSE around 09/16/2025, with an aggregate market value of $1,380,898.92.

How were the shares that are being sold acquired?

The 6,811 shares were acquired on 05/15/2025 through restricted stock vesting under a registered plan in exchange for services rendered.

Does the filing report any recent sales by related parties?

Yes, the IRWIN N GOLD FAMILY TRUST sold 5,000 common shares on 06/30/2025 for gross proceeds of $914,028.50.

Does the filer state there is undisclosed adverse information about HLI?

The filer represents by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.

Which broker and exchange are listed for the proposed sale?

The broker is listed as Morgan Stanley Smith Barney LLC and the exchange is the NYSE.
Houlihan Lokey Inc

NYSE:HLI

HLI Rankings

HLI Latest News

HLI Latest SEC Filings

HLI Stock Data

12.27B
54.44M
0.13%
103.13%
1.21%
Capital Markets
Investment Advice
Link
United States
LOS ANGELES